Non-Radiographic Axial Spondyloarthritis Market Insights, Epidemiology, and Market Forecast-2030

September 04 19:15 2020
Non-Radiographic Axial Spondyloarthritis Market Insights, Epidemiology, and Market Forecast-2030

(Albany, US) DelveInsight has launched a new report on Non-Radiographic Axial Spondyloarthritis Market

 

DelveInsight’s “Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA), historical and forecasted epidemiology as well as the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market report provides current treatment practices, emerging drugs, Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market share of the individual therapies, current and forecasted Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

 

Axial spondyloarthritis (axSpA) is an umbrella term inflammatory arthritis types that primarily affects the spine and the sacroiliac (SI) joints that connect the lower spine to the pelvis, resulting in pain in the lower back, hips, and buttocks. There are two subtypes of axSpA: Non-radiographic axial spondyloarthritis (nr-axSpA) and Ankylosing spondylitis (AS). “Non-radiographic” means that damage to the joints is not visible on X-ray. When changes to the vertebrae (the bones of the spine) or SI joints do not show any an X-ray changes, it is known as nr-axSpA. Once the joints are affected by an X-ray, a person can be diagnosed with AS. Up to 6% of people with chronic back pain will ultimately receive a diagnosis of axial spondyloarthritis. However, the disease often takes as long as 10 years to be diagnosed—a delay that can hugely impact your quality of life and lead to disability, missed time at work, and increased healthcare costs. Even worse, since the disease is progressive, you may become more debilitated over time. Left untreated, the vertebrae in your spine can fuse. Unfortunately, awareness of axial spondyloarthritis, including symptoms and what it takes to get diagnosed, is severely lacking. Here’s the scoop on this little-known disease.

 

View Free Sample Page:-  https://www.delveinsight.com/sample-request/non-radiographic-axial-spondyloarthritis-nraxspa-market

 

Non-Radiographic Axial Spondyloarthritis Treatment

Non-pharmacological treatment (first of all, education and regular exercises) is considered to be of nearly the same importance as NSAIDs in the first-line therapy of axSpA. It is generally accepted that regular exercise/physiotherapy effectively reduces symptoms and increases function and spinal mobility in axSpA in a short-term perspective that is also supported by evidence. However, the influence of non-pharmacological treatment on the long-term outcomes and radiographic spinal progression is less clear. COSENTYX (secukinumab) is a prescription medicine used to treat adults with active non-radiographic axial spondyloarthritis and objective signs of inflammation.

 

Non-Radiographic Axial Spondyloarthritis Market

The Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. This segment gives a thorough detail of Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

 

Non-Radiographic Axial Spondyloarthritis Report Scope

  • The report covers the descriptive overview of Non-Radiographic Axial Spondyloarthritis (nr-AxSpA), explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market

 

Download Free Sample Page:-  https://www.delveinsight.com/sample-request/non-radiographic-axial-spondyloarthritis-nraxspa-market

 

Table of content

1. Key Insights

2. Executive Summary of Non-Radiographic Axial Spondyloarthritis (nr-AxSpA)

3. Competitive Intelligence Analysis for Non-Radiographic Axial Spondyloarthritis (nr-AxSpA)

4. Non-Radiographic Axial Spondyloarthritis (nr-AxSpA): Market Overview at a Glance

5. Non-Radiographic Axial Spondyloarthritis (nr-AxSpA): Disease Background and Overview

6. Patient Journey

7. Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) Treatment

11. Marketed Products

12. Emerging Therapies

13. Non-Radiographic Axial Spondyloarthritis (nr-AxSpA): Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Non-Radiographic Axial Spondyloarthritis (nr-AxSpA)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Why should you buy this report?

  • The report will help in developing business strategies by understanding trends shaping and driving the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market
  • To understand the future market competition in the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market
  • To understand the future market competition in the Non-Radiographic Axial Spondyloarthritis (nr-AxSpA) market

 

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/ghaziabadonline/faridabadonlinejournal.in/wp-content/themes/gadgetine-theme/includes/single/post-tags-categories.php on line 7